- Home
- Industry Reports
- Healthcare
- Pharmaceuticals
- Asia Pacific Pharmaceutical Excipients Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Pharmaceutical Excipients are substances other than pharmacologically active drug components, which are included in the drug manufacturing process or contained in a finished pharmaceutical product dosage form. They facilitate formulation design and perform a range of functions such as enhancing flowability, increasing lubricity, improving compressibility, etc.
Asia-Pacific Pharmaceutical Excipients Market Segments Size & Growth:
Asia-Pacific pharmaceutical excipients market size is projected to reach approximately $3.95 billion by the end of 2024 with a CAGR of close to 5.78% from $1.95 billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include a rise in the incidence of diseases which has increased the demand for drugs, inventions of new excipients in the pharma industry and advancements in the techniques and equipment manufacturing excipients. However, Risk of adverse reactions on the body and stringent FDA guidelines for approval are thereby hampering the market growth.
Asia-Pacific Pharmaceutical Excipients Market Segments Share:
Asia-Pacific pharmaceutical excipients market is categorised into Process which comprise Diluents, Binders, Disintegrants, Glidants, Lubricants, Flavoring agents, Coloring agents and Coatings & Films. By Type of Product, the market is segmented into Organic and Inorganic Chemicals. Among these Organic chemicals, segment accounted for the largest share of the pharmaceutical excipients market, followed by inorganic chemicals. The large share of Organic Chemicals can be attributed to the wide applications in the manufacturing of pharmaceutical drugs. By Geography, India and China are projected to dominate the market with largest share and Asia-Pacific remains the dominant region regarding growth because of the low cost of raw materials, availability of cost-effective workforce and untapped resources it offers regarding manufacturing facilities.
Asia-Pacific Pharmaceutical Excipients Market Trends:
- SIO, an Archer Daniels Midland Company, presented a new range of innovative products and capabilities at CPhI 2016 in Barcelona.
- Merck Millipore, a leading science, and technology company, announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry to help solve the toughest problems in life science.
- FMC Corporation announced the signing of a definitive agreement with Nufarm Limited to divest a portion of FMC’s European herbicide portfolio.
Asia-Pacific Pharmaceutical Excipients Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary market players, such as
- Ashland Inc.
- AkzoNobel
- Archer Daniels Midland Company
- Associated British Foods PLC
- BASF SE
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1 Emergence of new excipients for the pharmaceutical industry
4.1.2 Advances in nanotechnology imparting new functions to pharmaceutical excipients
4.1.3 Patent cliffs driving the growth of excipients in the generics market
4.1.4 Growth of the global pharmaceuticals market backed by functional excipients
4.2 Restraints
4.2.1 Risk of adverse reactions on the body
4.2.2 Declining R&D Investments
4.2.3 Increased regulatory requirements leading to shortage of FDA approved manufacturing sites
4.3 Opportunities
4.3.1 Shifting focus of pharmaceutical manufacturing to emerging countries
4.3.2 Multi-functionality excipients are proving to be emerging areas of new product developments
4.4 Challenges
4.4.1 Quality concerns
5. Asia-Pacific Pharmaceutical Excipients Market – By Process
5.1 Coatings & Films
5.2 Coloring agents
5.3 Flavoring agents
5.4 Lubricants
5.5 Glidants
5.6 Disintegrants
5.7 Binders
5.8 Diluents
6. Asia-Pacific Pharmaceutical Excipients Market – By Type of Product
6.1 Organic Chemicals
6.2 Inorganic Chemicals
7. Asia-Pacific Pharmaceutical Excipients Market – By Country
7.1. Introduction
7.2. India
7.3. China
7.4. Japan
7.5 Rest of Asia-Pacific
8. Company Profiles
8.1 The Lubrizol Corporation
8.2 The Dow Chemical Company
8.3 J.M. Huber Corporation
8.4 Innophos Holdings Inc.,
8.5 Croda International PLC
8.6 Colorcon, Inc.
8.7 Archer Daniels Midland Company
8.8 AkzoNobel
8.9 Ashland Inc.
8.10 Associated British Foods PLC
8.11 BASF SE,
8.12 Evonik Industries AG
8.13 FMC Corporation
8.14 Merck Millipore
8.15 Roquette Group
9. Asia-Pacific Pharmaceutical Excipients Market – Competitive Landscape
9.1 Market Share Analysis
9.2 Strategies Adopted by top companies
9.3 Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1 Insights of Industry Experts
10.2 Investment Opportunities
10.3 Analyst Opinion
11. Appendix
11.1 List of Tables
11.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €1,988.22 - €6,627.39
- INR: ₹179,956.59 - ₹599,855.30
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,698.73 - £5,662.44
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Pharmaceutical Excipients are substances other than pharmacologically active drug components, which are included in the drug manufacturing process or contained in a finished pharmaceutical product dosage form. They facilitate formulation design and perform a range of functions such as enhancing flowability, increasing lubricity, improving compressibility, etc.
Asia-Pacific Pharmaceutical Excipients Market Segments Size & Growth:
Asia-Pacific pharmaceutical excipients market size is projected to reach approximately $3.95 billion by the end of 2024 with a CAGR of close to 5.78% from $1.95 billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include a rise in the incidence of diseases which has increased the demand for drugs, inventions of new excipients in the pharma industry and advancements in the techniques and equipment manufacturing excipients. However, Risk of adverse reactions on the body and stringent FDA guidelines for approval are thereby hampering the market growth.
Asia-Pacific Pharmaceutical Excipients Market Segments Share:
Asia-Pacific pharmaceutical excipients market is categorised into Process which comprise Diluents, Binders, Disintegrants, Glidants, Lubricants, Flavoring agents, Coloring agents and Coatings & Films. By Type of Product, the market is segmented into Organic and Inorganic Chemicals. Among these Organic chemicals, segment accounted for the largest share of the pharmaceutical excipients market, followed by inorganic chemicals. The large share of Organic Chemicals can be attributed to the wide applications in the manufacturing of pharmaceutical drugs. By Geography, India and China are projected to dominate the market with largest share and Asia-Pacific remains the dominant region regarding growth because of the low cost of raw materials, availability of cost-effective workforce and untapped resources it offers regarding manufacturing facilities.
Asia-Pacific Pharmaceutical Excipients Market Trends:
- SIO, an Archer Daniels Midland Company, presented a new range of innovative products and capabilities at CPhI 2016 in Barcelona.
- Merck Millipore, a leading science, and technology company, announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry to help solve the toughest problems in life science.
- FMC Corporation announced the signing of a definitive agreement with Nufarm Limited to divest a portion of FMC’s European herbicide portfolio.
Asia-Pacific Pharmaceutical Excipients Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary market players, such as
- Ashland Inc.
- AkzoNobel
- Archer Daniels Midland Company
- Associated British Foods PLC
- BASF SE
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1 Emergence of new excipients for the pharmaceutical industry
4.1.2 Advances in nanotechnology imparting new functions to pharmaceutical excipients
4.1.3 Patent cliffs driving the growth of excipients in the generics market
4.1.4 Growth of the global pharmaceuticals market backed by functional excipients
4.2 Restraints
4.2.1 Risk of adverse reactions on the body
4.2.2 Declining R&D Investments
4.2.3 Increased regulatory requirements leading to shortage of FDA approved manufacturing sites
4.3 Opportunities
4.3.1 Shifting focus of pharmaceutical manufacturing to emerging countries
4.3.2 Multi-functionality excipients are proving to be emerging areas of new product developments
4.4 Challenges
4.4.1 Quality concerns
5. Asia-Pacific Pharmaceutical Excipients Market – By Process
5.1 Coatings & Films
5.2 Coloring agents
5.3 Flavoring agents
5.4 Lubricants
5.5 Glidants
5.6 Disintegrants
5.7 Binders
5.8 Diluents
6. Asia-Pacific Pharmaceutical Excipients Market – By Type of Product
6.1 Organic Chemicals
6.2 Inorganic Chemicals
7. Asia-Pacific Pharmaceutical Excipients Market – By Country
7.1. Introduction
7.2. India
7.3. China
7.4. Japan
7.5 Rest of Asia-Pacific
8. Company Profiles
8.1 The Lubrizol Corporation
8.2 The Dow Chemical Company
8.3 J.M. Huber Corporation
8.4 Innophos Holdings Inc.,
8.5 Croda International PLC
8.6 Colorcon, Inc.
8.7 Archer Daniels Midland Company
8.8 AkzoNobel
8.9 Ashland Inc.
8.10 Associated British Foods PLC
8.11 BASF SE,
8.12 Evonik Industries AG
8.13 FMC Corporation
8.14 Merck Millipore
8.15 Roquette Group
9. Asia-Pacific Pharmaceutical Excipients Market – Competitive Landscape
9.1 Market Share Analysis
9.2 Strategies Adopted by top companies
9.3 Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1 Insights of Industry Experts
10.2 Investment Opportunities
10.3 Analyst Opinion
11. Appendix
11.1 List of Tables
11.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.